Novelion to Cut an Unknown Number of Jobs in Restructuring Post author:Sam Post published:January 25, 2018 Post category:BioPharma Novelion will slash an unknown number of jobs as it initiates “significant cost reduction plans.” Source: BioSpace You Might Also Like ADMA Biologics, Inc. Provides Corporate Update And Reports First Quarter 2017 Financial Results May 14, 2017 Gamida Cell Taps Former Clal Biotech CSO as New Leader November 19, 2017 Array BioPharma Slaps $192M Lawsuit on AstraZeneca Over Cancer Drug Royalties February 1, 2018
ADMA Biologics, Inc. Provides Corporate Update And Reports First Quarter 2017 Financial Results May 14, 2017